Heterogeneity of gestational diabetes (GDM) and challenges in developing a GDM risk score

被引:27
|
作者
Huvinen, Emilia [1 ,2 ]
Eriksson, Johan G. [2 ,3 ,4 ]
Stach-Lempinen, Beata [5 ]
Tiitinen, Aila [1 ]
Koivusalo, Saila B. [1 ]
机构
[1] Univ Helsinki, Helsinki Univ Hosp, Dept Obstet & Gynaecol, Helsinki, Finland
[2] Univ Helsinki, Unit Gen Practice & Primary Hlth Care, Tukholmankatu 8 B,POB 20, Helsinki 00014, Finland
[3] Folkhalsan Res Ctr, Helsinki, Finland
[4] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland
[5] South Karelia Cent Hosp, Dept Obstet & Gynaecol, Lappeenranta, Finland
基金
芬兰科学院; 欧盟地平线“2020”;
关键词
Gestational diabetes; Pregnancy; Prediction of diabetes; Screening; Obesity; Heterogeneity; LIFE-STYLE INTERVENTION; DIAGNOSTIC-CRITERIA; PREGNANCY; HYPERGLYCEMIA; PREVENTION; PREDICTION; MELLITUS; WOMEN; INSULIN; RADIEL;
D O I
10.1007/s00592-018-1224-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AimsGestational diabetes (GDM) affects a growing number of women and identification of individuals at risk, e.g., with risk prediction models, would be important. However, the performance of GDM risk scores has not been optimal. Here, we assess the impact of GDM heterogeneity on the performance of two top-rated GDM risk scores.MethodsThis is a substudy of the RADIEL triala lifestyle intervention study including women at high GDM risk. We assessed the GDM risk score by Teede and that developed by Van Leeuwen in our high-risk cohort of 510 women. To investigate the heterogeneity of GDM, we further divided the women according to GDM history, BMI, and parity. With the goal of identifying novel predictors of GDM, we further analyzed 319 women with normal glucose tolerance in the first trimester.ResultsBoth risk scores underestimated GDM incidence in our high-risk cohort. Among women with a BMI30kg/m(2) and/or previous GDM, 49.4% developed GDM and 37.4% received the diagnosis already in the first trimester. Van Leeuwen score estimated a 19% probability of GDM and Teede succeeded in risk identification in 61%. The lowest performance of the risk scores was seen among the non-obese women. Fasting plasma glucose, HbA(1c), and family history of diabetes were predictors of GDM in the total study population. Analysis of subgroups did not provide any further information.ConclusionsOur findings suggest that the marked heterogeneity of GDM challenges the development of risk scores for detection of GDM.
引用
收藏
页码:1251 / 1259
页数:9
相关论文
共 50 条
  • [41] Educational and intervention programmes for gestational diabetes mellitus (GDM) management: An integrative review
    Carolan-Olah, Mary C.
    COLLEGIAN, 2016, 23 (01) : 103 - 114
  • [42] Effects of Fish Oil Supplementation on Gestational Diabetes Mellitus (GDM): A Systematic Review
    Ostadrahimi, Alireza
    Mohammad-Alizadeh, Sakineh
    Mirgafourvand, Mozhgan
    Yaghoubi, Sina
    Shahrisa, Elham
    Farshbaf-Khafili, Azizeh
    IRANIAN RED CRESCENT MEDICAL JOURNAL, 2016, 18 (11)
  • [43] Does the gestational age at which the glucose challenge test (GCT) is conducted influence the diagnosis of gestational diabetes mellitus (GDM)?
    Pardo, Ella
    Yagur, Yael
    Gluska, Hadar
    Cohen, Gal
    Kovo, Michal
    Biron-Shental, Tal
    Weitzner, Omer
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2024, 310 (03) : 1593 - 1598
  • [44] Heterogeneity of gestational diabetes (GDM) and long-term risk of diabetes and metabolic syndrome: findings from the RADIEL study follow-up
    Emilia Huvinen
    Johan G. Eriksson
    Saila B. Koivusalo
    Nora Grotenfelt
    Aila Tiitinen
    Beata Stach-Lempinen
    Kristiina Rönö
    Acta Diabetologica, 2018, 55 : 493 - 501
  • [45] Gestational weight gain among nutritionally treated GDM patients
    Shmueli, Anat
    Borovich, Adi
    Bergel, Riki
    Ovadia, Tamar
    Hiersch, Liran
    Ashwal, Eran
    Yogev, Yariv
    Aviram, Amir
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2018, 31 (09) : 1177 - 1181
  • [46] Combined Metabolomic Analysis of Plasma and Urine Reveals AHBA, Tryptophan and Serotonin Metabolism as Potential Risk Factors in Gestational Diabetes Mellitus (GDM)
    Leitner, Miriam
    Fragner, Lena
    Danner, Sarah
    Holeschofsky, Nastassja
    Leaner, Karoline
    Tischler, Sonja
    Doerfler, Hannes
    Bachmann, Gert
    Sun, Xiaoliang
    Jaeger, Walter
    Kautzky-Willer, Alexandra
    Weckwerth, Wolfram
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2017, 4
  • [47] Advanced maternal age (AMA) and 75 g oGTT glucose levels are pedictors for Insulin therapy in women with gestational diabetes (GDM)
    Josefine Theresia, Koenigbauer
    Laura, Fangmann
    Paul, Rostin
    Selina, Balke
    Petra, Weid
    Wolfgang, Henrich
    Alexander, Weichert
    Goebl, Christian
    JOURNAL OF PERINATAL MEDICINE, 2023, 51 (09) : 1154 - 1162
  • [48] Early screening and diagnosis of gestational diabetes mellitus (GDM) and its impact on perinatal outcomes
    Bastian, Beenu
    Smithers, Lisa Gaye
    Pape, Alexia
    Davis, Warren
    Fu, K.
    Francois, Monique
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2024, 217
  • [49] Development of Multimarker Diagnostic Models from Metabolomics Analysis for Gestational Diabetes Mellitus (GDM)
    Hou, Wolin
    Meng, Xiyan
    Zhao, Aihua
    Zhao, Weijing
    Pan, Jiemin
    Tang, Junling
    Huang, Yajuan
    Li, Huaping
    Jia, Wei
    Liu, Fang
    Jia, Weiping
    MOLECULAR & CELLULAR PROTEOMICS, 2018, 17 (03) : 431 - 441
  • [50] A Prospective Study to Determine if Management of Cases of Gestational Diabetes Mellitus (GDM) can be Modified
    Tripathi, Reva
    Gupta, Nidhi
    Mazhari, Farhat
    Gupta, Tanya
    JOURNAL OF OBSTETRICS AND GYNECOLOGY OF INDIA, 2022, 72 (02) : 147 - 153